Reported about 2 months ago
Pfizer and BioNTech encountered a setback in their clinical trial for a combined vaccine targeting both influenza and COVID-19, as the Phase 3 trial did not meet a vital objective. This development raises concerns about the future of this innovative vaccine approach.
Source: YAHOO